{
    "id": "unbiased_care_hormone_therapy_selectAll_v1",
    "type": "selectAll",
    "stem": "The nurse is providing education for a transgender woman starting feminizing hormone therapy (e.g., estradiol and spironolactone). Which safety and educational points should the nurse include?",
    "options": [
        {
            "id": "a",
            "text": "Notify the provider for sudden unilateral leg pain or swelling."
        },
        {
            "id": "b",
            "text": "Expect to see permanent breast development within 3-6 months."
        },
        {
            "id": "c",
            "text": "Limit intake of high-potassium foods (e.g., bananas, potatoes)."
        },
        {
            "id": "d",
            "text": "Avoid using tobacco products, as they significantly increase blood clot risk."
        },
        {
            "id": "e",
            "text": "Report any significant mood changes or symptoms of depression."
        },
        {
            "id": "f",
            "text": "Maintain a diet high in sodium and fluids to prevent hypotension."
        }
    ],
    "correctOptionIds": [
        "a",
        "b",
        "c",
        "d",
        "e"
    ],
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    },
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 4,
        "topicTags": [
            "Unbiased Care",
            "Pharmacology",
            "Gender-Affirming Care",
            "Endocrine",
            "Safety"
        ],
        "questionTrap": "The primary trap is focusing solely on the diuretic property of spironolactone and incorrectly applying standard interventions for hypotension. Test-takers may recognize that diuretics can lower blood pressure and then select the option to increase sodium and fluids, a common intervention for hypovolemia. This reasoning fails to account for three critical factors: 1) Spironolactone's primary risk is hyperkalemia, not hypotension; 2) Estradiol causes sodium/fluid retention, counteracting spironolactone's effect on blood pressure; and 3) A high-sodium diet is contraindicated due to the combined cardiovascular risks.",
        "mnemonics": "Remember the key risks of feminizing hormone therapy with **'Hormone Therapy CLOTS & K+'**:\n**C** - **C**lots (VTE risk from Estrogen).\n**L** - **L**eg pain/swelling (DVT sign).\n**O** - M**oo**d changes (Report depression/anxiety).\n**T** - **T**obacco is contraindicated (Synergistic risk).\n**S** - **S**pironolactone... \n**K+** - ...spares **K**+ (Potassium), risk for hyperkalemia."
    },
    "answerBreakdown": {
        "a": {
            "correct": true,
            "content": "Estrogen promotes a hypercoagulable state by increasing the hepatic synthesis of pro-thrombotic factors (e.g., Factor VII, fibrinogen) and decreasing the synthesis of natural anticoagulants (e.g., antithrombin, Protein S). This imbalance elevates the risk for venous thromboembolism (VTE). Sudden unilateral leg pain, swelling, warmth, and erythema are cardinal signs of a deep vein thrombosis (DVT), a medical emergency requiring immediate notification of the provider."
        },
        "b": {
            "correct": true,
            "content": "Estradiol directly stimulates estrogen receptors in the mammary glands, promoting ductal proliferation and stromal tissue growth. This physiological process results in permanent breast development (thelarche), a desired secondary sex characteristic for feminization. The onset of these changes typically occurs within 3-6 months of initiating therapy, with full development taking 2-3 years."
        },
        "c": {
            "correct": true,
            "content": "Spironolactone is an aldosterone antagonist that functions as a potassium-sparing diuretic. It acts on the distal renal tubules to inhibit the sodium-potassium exchange mechanism, leading to sodium excretion and potassium retention. This action creates a significant risk for hyperkalemia, an electrolyte imbalance that can cause life-threatening cardiac dysrhythmias. Therefore, limiting dietary intake of potassium-rich foods is a crucial safety measure."
        },
        "d": {
            "correct": true,
            "content": "Tobacco use independently increases VTE risk by inducing endothelial dysfunction and promoting platelet aggregation. When combined with estrogen's pro-thrombotic effects, the risk is not merely additive but synergistic, significantly elevating the danger of developing a DVT or pulmonary embolism (PE). Cessation of all tobacco products is a critical harm-reduction strategy."
        },
        "e": {
            "correct": true,
            "content": "Hormones like estrogen and androgens modulate neurotransmitter systems (e.g., serotonin, dopamine) in brain regions responsible for mood regulation. The profound shift in the hormonal milieu during gender-affirming therapy can alter emotional processing and neurochemistry, potentially precipitating or exacerbating mood disorders like depression or anxiety. Monitoring for and reporting these changes is essential for mental health support and potential treatment adjustments."
        },
        "f": {
            "correct": false,
            "content": "This instruction is incorrect and potentially harmful. While spironolactone's diuretic effect can cause a mild decrease in blood pressure, estradiol often causes sodium and water retention, which can increase blood pressure. Recommending a high-sodium diet would directly oppose the therapeutic effect of spironolactone and worsen estrogen-induced fluid retention, increasing the risk for hypertension and cardiovascular strain."
        }
    }
}